NCT06896890 2025-03-26
Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
Inhatarget Therapeutics
Phase 1/2 Recruiting
Inhatarget Therapeutics
Purdue University
Bern University of Applied Sciences